Corcept Therapeutics Incorporated
DE ˙ DB ˙ US2183521028
63,24 € ↓ -0,74 (-1,16%)
2026-06-05
DEL PRIS
SecurityDE:HTD / Corcept Therapeutics Incorporated
InstitutionEnvestnet Asset Management Inc
Latest Disclosed Ownership41,860 shares
Latest Disclosed Value $ 1,687,367
Envestnet Asset Management Inc reports 3.64% decrease in ownership of HTD / Corcept Therapeutics Incorporated

On May 4, 2026 - Envestnet Asset Management Inc filed a 13F-HR form disclosing ownership of 41,860 shares of Corcept Therapeutics Incorporated (DE:HTD) valued at $1,443,751 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 43,442 shares of Corcept Therapeutics Incorporated. This represents a change in shares of -3.64% during the quarter. The current value of the position is $2,647,226 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-04 2026-03-31 13F CORCEPT THERAPEUTICS COM 218352102 41,860 -1,582 -3.64 1,687 11.65 0.0005
2026-02-10 2025-12-31 13F CORCEPT THERAPEUTICS COM 218352102 43,442 3,676 9.24 1,512 -54.27 0.0004
2025-11-05 2025-09-30 13F CORCEPT THERAPEUTICS COM 218352102 39,766 919 2.37 3,305 15.89 0.0010
2025-08-01 2025-06-30 13F CORCEPT THERAPEUTICS COM 218352102 38,847 7,077 22.28 2,851 -21.42 0.0008
2025-04-29 2025-03-31 13F CORCEPT THERAPEUTICS COM 218352102 31,770 2,613 8.96 3,629 146.97 0.0012
2025-02-13 2024-12-31 13F CORCEPT THERAPEUTICS COM 218352102 29,157 -5,030 -14.71 1,469 -7.14 0.0005
2024-11-07 2024-09-30 13F CORCEPT THERAPEUTICS COM 218352102 34,187 -37,698 -52.44 1,582 -32.25 0.0005
2024-08-08 2024-06-30 13F CORCEPT THERAPEUTICS COM 218352102 71,885 29 0.04 2,336 29.01 0.0008
2024-05-13 2024-03-31 13F CORCEPT THERAPEUTICS COM 218352102 71,856 56,700 374.11 1,810 267.89 0.0007
2024-02-13 2023-12-31 13F CORCEPT THERAPEUTICS COM 218352102 15,156 -5,013 -24.85 492 -10.38 0.0002
2023-11-13 2023-09-30 13F CORCEPT THERAPEUTICS COM 218352102 20,169 -50,633 -71.51 550 -65.14 0.0003
2023-08-04 2023-06-30 13F CORCEPT THERAPEUTICS COM 218352102 70,802 -136,348 -65.82 1,575 -46.57 0.0007
2023-05-11 2023-03-31 13F CORCEPT THERAPEUTICS COM 218352102 207,150 74,509 56.17 2,948 9.47 0.0014
2023-02-07 2022-12-31 13F CORCEPT THERAPEUTICS COM 218352102 132,641 8,268 6.65 2,694 -15.55 0.0014
2022-11-10 2022-09-30 13F CORCEPT THERAPEUTICS COM 218352102 124,373 6,194 5.24 3,189 13.49 0.0018
2022-08-03 2022-06-30 13F CORCEPT THERAPEUTICS COM 218352102 118,179 7,104 6.40 2,810 12.36 0.0016
2022-05-04 2022-03-31 13F CORCEPT THERAPEUTICS COM 218352102 111,075 27,267 32.54 2,501 50.75 0.0013
2022-02-04 2021-12-31 13F CORCEPT THERAPEUTICS COM 218352102 83,808 7,702 10.12 1,659 10.75 0.0008
2021-10-07 2021-09-30 13F CORCEPT THERAPEUTICS COM 218352102 76,106 7,538 10.99 1,498 -0.66 0.0008
2021-08-04 2021-06-30 13F CORCEPT THERAPEUTICS COM 218352102 68,568 13,126 23.68 1,508 14.33 0.0009
2021-05-04 2021-03-31 13F CORCEPT THERAPEUTICS COM 218352102 55,442 12,118 27.97 1,319 16.42 0.0009
2021-02-02 2020-12-31 13F CORCEPT THERAPEUTICS COM 218352102 43,324 4,884 12.71 1,133 69.36 0.0009
2020-10-09 2020-09-30 13F CORCEPT THERAPEUTICS COM 218352102 38,440 8,932 30.27 669 34.88 0.0006
2020-07-08 2020-06-30 13F CORCEPT THERAPEUTICS COM 218352102 29,508 5,864 24.80 496 76.51 0.0005
2020-04-23 2020-03-31 13F CORCEPT THERAPEUTICS COM 218352102 23,644 8,374 54.84 281 51.89 0.0003
2020-02-11 2019-12-31 13F CORCEPT THERAPEUTICS COM 218352102 15,270 -2,457 -13.86 185 -26.29 0.0002
2019-10-17 2019-09-30 13F CORCEPT THERAPEUTICS COM 218352102 17,727 1,015 6.07 251 34.95 0.0003
2019-08-02 2019-06-30 13F CORCEPT THERAPEUTICS COM 218352102 16,712 16,712 186 0.0002
2019-05-10 2019-03-31 13F CORCEPT THERAPEUTICS COM 218352102 0 -56,847 -100.00 0 -100.00
2019-02-12 2018-12-31 13F CORCEPT THERAPEUTICS COM 218352102 56,847 56,847 759 0.0012
2018-11-14 2018-09-30 13F CORCEPT THERAPEUTICS COM 218352102 0 -10,571 -100.00 0 -100.00
2018-08-10 2018-06-30 13F CORCEPT THERAPEUTICS COM 218352102 10,571 -2,483 -19.02 165 -23.61 0.0004
2018-05-09 2018-03-31 13F CORCEPT THERAPEUTICS COM 218352102 13,054 12,760 4,340.14 216 4,220.00 0.0006
2018-02-20 2017-12-31 13F CORCEPT THERAPEUTICS COM 218352102 294 0 0.00 5 -16.67 0.0000
2017-11-13 2017-09-30 13F CORCEPT THERAPEUTICS COM 218352102 294 -3,000 -91.07 6 -84.21 0.0000
2017-08-14 2017-06-30 13F CORCEPT THERAPEUTICS COM 218352102 3,294 3,000 1,020.41 38 1,166.67 0.0001
2017-05-09 2017-03-31 13F CORCEPT THERAPEUTICS COM 218352102 294 0 0.00 3 50.00 0.0000
2017-02-14 2016-12-31 13F CORCEPT THERAPEUTICS COM 218352102 294 -2,706 -90.20 2 -90.00 0.0000
2016-11-14 2016-09-30 13F CORCEPT THERAPEUTICS COM 218352102 3,000 -294 -8.93 20 11.11 0.0001
2016-08-15 2016-06-30 13F CORCEPT THERAPEUTICS COM 218352102 3,294 0 0.00 18 20.00 0.0001
2016-05-16 2016-03-31 13F CORCEPT THERAPEUTICS COM 218352102 3,294 3,294 0.00 15 0.0001
2015-02-12 2014-12-31 13F Corcept Therapeutics COM 218352102 0 -3,500 -100.00 0 -100.00
2014-11-13 2014-09-30 13F Corcept Therapeutics COM 218352102 3,500 3,500 9 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.